MICROBIAL PRODUCTION - Cutting-edge inABLE® technology: The key to cost-effective production of a novel antimicrobial peptide with potential for the treatment of MRSA

I Fotheringham; M Upton

MICROBIAL PRODUCTION - Cutting-edge inABLE® technology: The key to cost-effective production of a novel antimicrobial peptide with potential for the treatment of MRSA

I Fotheringham
, M Upton

School of Biomedical Sciences

Research output: Book/Report › Commissioned report › peer-review

Original language	English
Publication status	Published - 1 Jun 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

TY - BOOK

T1 - MICROBIAL PRODUCTION - Cutting-edge inABLE® technology: The key to cost-effective production of a novel antimicrobial peptide with potential for the treatment of MRSA

AU - Fotheringham, I

AU - Upton, M

PY - 2016/6/1

Y1 - 2016/6/1

M3 - Commissioned report

BT - MICROBIAL PRODUCTION - Cutting-edge inABLE® technology: The key to cost-effective production of a novel antimicrobial peptide with potential for the treatment of MRSA

ER -